We are excited to work in collaboration with EPFL and SunRegen to test the efficacy of a small neuroprotective compound on ALS/FTD.
We are thrilled to initiate our first R21 grant, recently awarded by NINDS, aiming at testing an immunotherapy approach for ALS/FTD.
We are so proud of our Pierre De Rossi for receiving the prestigious Career Development Award from the Synapsis foundation!
Congratulations to our Vera for receiving the highly competitive long-term postdoctoral fellowship from the Federation of European Biochemical Societies. Well done Vera!
Our new review on the role of liquid-liquid phase separation in neurodegenerative diseases is out in Developmental Cell. A special treat to all Star Wars fans out there. May the force be with you.
The Polymenidou group receives competitive EU Consortium Grant. Read the details on the DQBM News webpage.
Read here Magda's publication: "A gut feeling about C9ORF72". Take advantage here of a 50 days' free access to read and download Magda's article with no sign up, registration or fees required until October 16, 2020!
The SNF funding for our lab was extended for another two years!
Magda received an Investigator Initiated Award by the ALS Association!
Our study on TDP-43 oligomerization featured by the Faculty of Science of our University!
Our paper on physiological TDP-43 oligomerization is finally out!
The Joining Forces Symposium focused on Protein Aggregation in Health and Disease that Magda co-organized together with colleagues at the ETH Zurich was a big success! We were all there and enjoyed two days of fascinating talks and intense discussions.
Our lab receives a Target ALS Consortium grant to test the efficacy of anti-DPR immunotherapy for C9 ALS.
Our lab receives SNF Sinergia grant! We are excited to team up with the groups of Ben Schuler, Fred Allain, GunnarJeschke and Paolo Paganetti to study the role of disordered regions in RNA-binding proteins for function and pathology.